Atlas Trials

Ocriplasmin Research to Better Inform Treatment (ORBIT)

Clinical trial NCT02079883 · COMPLETED

Trial details

NCT number
NCT02079883
Sponsor
ThromboGenics
Status
COMPLETED
Study type
OBSERVATIONAL
Symptomatic Vitreomacular Adhesion
Start date
2014-05-01
Primary completion
2016-05-01
Enrollment
540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.